Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilbert J Burckart

Showing results (61-70 of 129) with videos related to

Pageof 13
Sort By:
Pediatric Transplantation|July 24, 2010
Inosine 5'-monophosphate dehydrogenase 1 haplotypes and association with mycophenolate mofetil gastrointestinal intolerance in pediatric heart transplant patientsErin L Ohmann, Gilbert J Burckart, Yan Chen, et al.
Clinical Pharmacology and Therapeutics|December 12, 2017
Pediatric Development of Molecularly Targeted Oncology DrugsShivam Kamlesh Patel, Ruby Leong, Hong Zhao, et al.
Journal of Clinical Pharmacology|March 22, 2005
Sequential analysis of tacrolimus dosing in adult lung transplant patients with ABCB1 haplotypesHongxia Zheng, Erin Schuetz, Adriana Zeevi, et al.
Pharmacogenetics and Genomics|May 15, 2007
A novel variant L263F in human inosine 5'-monophosphate dehydrogenase 2 is associated with diminished enzyme activityJian Wang, Adriana Zeevi, Steve Webber, et al.
Journal of Clinical Pharmacology|July 8, 2024
Labetalol Dosing in Pregnancy: PBPK/PD and CYP2C19 PolymorphismsXiaomei I Liu, Dionna J Green, John van den Anker, et al.
Journal of Clinical Pharmacology|September 23, 2022
Pediatric Efficacy Extrapolation in Drug Development Submitted to the US Food and Drug Administration 2015-2020Sherbet Samuels, Kyunghun Park, Varsha Bhatt-Mehta, et al.
Clinical Pharmacology and Therapeutics|November 19, 2025
Pediatric Developmental Safety Assessment: Are We Ready for the Next Thalidomide?Gilbert J Burckart, Susan M Abdel-Rahman, Gelareh Abulwerdi, et al.
Clinical Pharmacology and Therapeutics|November 18, 2018
Dosage Considerations for Canakinumab in Children With Periodic Fever SyndromesLuning Zhuang, Jianmeng Chen, Jingyu Yu, et al.
Therapeutic Innovation & Regulatory Science|August 15, 2017
Neonatal Safety Information Reported to the FDA During Drug Development StudiesDebbie Avant, Gerri Baer, Jason Moore, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 7, 2018
Assessing CYP2C19 Ontogeny in Neonates and Infants Using Physiologically Based Pharmacokinetic Models: Impact of Enzyme Maturation Versus InhibitionPeng Duan, Fang Wu, Jason N Moore, et al.
Pageof 13

Showing results (61-70 of 129) with videos related to

Sort By:
Pageof 13
Pediatric Transplantation|July 24, 2010
Inosine 5'-monophosphate dehydrogenase 1 haplotypes and association with mycophenolate mofetil gastrointestinal intolerance in pediatric heart transplant patientsErin L Ohmann, Gilbert J Burckart, Yan Chen, et al.
Clinical Pharmacology and Therapeutics|December 12, 2017
Pediatric Development of Molecularly Targeted Oncology DrugsShivam Kamlesh Patel, Ruby Leong, Hong Zhao, et al.
Journal of Clinical Pharmacology|March 22, 2005
Sequential analysis of tacrolimus dosing in adult lung transplant patients with ABCB1 haplotypesHongxia Zheng, Erin Schuetz, Adriana Zeevi, et al.
Pharmacogenetics and Genomics|May 15, 2007
A novel variant L263F in human inosine 5'-monophosphate dehydrogenase 2 is associated with diminished enzyme activityJian Wang, Adriana Zeevi, Steve Webber, et al.
Journal of Clinical Pharmacology|July 8, 2024
Labetalol Dosing in Pregnancy: PBPK/PD and CYP2C19 PolymorphismsXiaomei I Liu, Dionna J Green, John van den Anker, et al.
Journal of Clinical Pharmacology|September 23, 2022
Pediatric Efficacy Extrapolation in Drug Development Submitted to the US Food and Drug Administration 2015-2020Sherbet Samuels, Kyunghun Park, Varsha Bhatt-Mehta, et al.
Clinical Pharmacology and Therapeutics|November 19, 2025
Pediatric Developmental Safety Assessment: Are We Ready for the Next Thalidomide?Gilbert J Burckart, Susan M Abdel-Rahman, Gelareh Abulwerdi, et al.
Clinical Pharmacology and Therapeutics|November 18, 2018
Dosage Considerations for Canakinumab in Children With Periodic Fever SyndromesLuning Zhuang, Jianmeng Chen, Jingyu Yu, et al.
Therapeutic Innovation & Regulatory Science|August 15, 2017
Neonatal Safety Information Reported to the FDA During Drug Development StudiesDebbie Avant, Gerri Baer, Jason Moore, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 7, 2018
Assessing CYP2C19 Ontogeny in Neonates and Infants Using Physiologically Based Pharmacokinetic Models: Impact of Enzyme Maturation Versus InhibitionPeng Duan, Fang Wu, Jason N Moore, et al.
Pageof 13